'Con­sti­tu­tion­al ar­gu­ments fail': Gov­ern­ment lawyers slam suits from Bris­tol My­ers, Janssen over drug price ne­go­ti­a­tions

While stress­ing that the new gov­ern­ment price ne­go­ti­a­tion pro­gram is strict­ly vol­un­tary, gov­ern­ment lawyers made clear in a New Jer­sey fed­er­al court brief filed last night that both Bris­tol My­ers Squibb and Janssen’s pri­ma­ry le­gal the­o­ry — that the pro­gram rep­re­sents a “phys­i­cal” tak­ing of their prop­er­ty — is un­ten­able un­der the same Supreme Court cas­es that the com­pa­nies in­voke.

The court fil­ing, which again lays out HHS’ de­fense, comes as al­most a dozen phar­ma com­pa­nies have now filed suit over the In­fla­tion Re­duc­tion Act’s drug price ne­go­ti­a­tions in var­i­ous courts across the coun­try. Ear­li­er this month a fed­er­al judge sided with HHS in say­ing the ne­go­ti­a­tion time­line can pro­ceed, thus block­ing an ef­fort by the US Cham­ber of Com­merce to stop the ne­go­ti­a­tions be­fore they start.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER